Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
3,931,347
-
Share change
-
+2,024,358
-
Total reported value
-
$1,479,735
-
Price per share
-
$0.3765
-
Number of holders
-
23
-
Value change
-
+$760,417
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q1 2025
As of 31 Mar 2025 ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,931,347 shares of stock of the company.
Largest 10 holders included INGALLS & SNYDER LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, Virtu Financial LLC, CIBC WORLD MARKET INC., THOROUGHBRED FINANCIAL SERVICES, LLC, GROUP ONE TRADING LLC, RENAISSANCE TECHNOLOGIES LLC, Gradient Capital Advisors, LLC, and Federation des caisses Desjardins du Quebec.
This table shows 23 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.